Search

Search Results

1. Determining the optimal pharmacokinetic modelling and simplified quantification method of [¹⁸F]AlF-P16-093 for patients with primary prostate cancer (PPCa)

   Purpose

   This paper discusses the optimization of pharmacokinetic modelling and alternate simplified quantification method for [ ¹⁸ F]AlF-P16-093, a...

   Ruiyue Zhao, Zeheng **a, ... Tao Sun in European Journal of Nuclear Medicine and Molecular Imaging

   Article 29 January 2024
   

2. Preclinical evaluation and pilot clinical study of [¹⁸F]AlF-NOTA-FAPI-04 for PET imaging of rheumatoid arthritis

   Purpose

   Fibroblast-like synoviocytes (FLSs) are key effector cells in the inflamed joints of patients with rheumatoid arthritis (RA). Previous studies...

   Luna Ge, Zheng Fu, ... Lin Wang in European Journal of Nuclear Medicine and Molecular Imaging

   Article 18 June 2022
   

3. ImmunoPET/CT imaging of clear cell renal cell carcinoma with [¹⁸F]RCCB6: a first-in-human study

   Purpose

   The cluster of differentiation (CD70) is a potential biomarker of clear cell renal cell carcinoma (ccRCC). This study aims to develop...

   Qianyun Wu, Yanfei Wu, ... Weijun Wei in European Journal of Nuclear Medicine and Molecular Imaging

   Article 14 March 2024
   

4. Sodium Pump Na + /K + ATPase Subunit α1-Targeted Positron Emission Tomography Imaging of Hepatocellular Carcinoma in Mouse Models

   Purpose

   Positron emission tomography (PET) imaging was not efficiently used in the early diagnosis of hepatocellular carcinoma (HCC) due to the lack...

   Si Tang, **aoChun Yang, ... Wei Fan in Molecular Imaging and Biology

   Article 07 October 2021
   

5. ¹⁸F-labeled tracers targeting fibroblast activation protein

   Background

   Cancer-associated fibroblasts are found in the stroma of epithelial tumors. They are characterized by overexpression of the fibroblast...

   Thomas Lindner, Annette Altmann, ... Uwe Haberkorn in EJNMMI Radiopharmacy and Chemistry

   Article Open access 21 August 2021
   

6. Synthesis, preclinical evaluation, and a pilot clinical imaging study of [¹⁸F]AlF-NOTA-JR11 for neuroendocrine neoplasms compared with [⁶⁸Ga]Ga-DOTA-TATE

   Purpose

   A [ ¹⁸ F]AlF-labeled somatostatin receptor (SSTR) antagonist was developed for imaging of neuroendocrine neoplasms (NENs), evaluated and...

   Qing **e, Teli Liu, ... Zhi Yang in European Journal of Nuclear Medicine and Molecular Imaging

   Article 25 February 2021
   

7. [¹⁸F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [⁶⁸Ga]Ga-DOTATATE in neuroendocrine tumour patients

   Purpose

   The widespread use of gallium-68-labelled somatostatin analogue (SSA) PET, the current standard for somatostatin receptor (SSTR) imaging, is...

   Elin Pauwels, Frederik Cleeren, ... Christophe M. Deroose in European Journal of Nuclear Medicine and Molecular Imaging

   Article 02 July 2020
   

8. Biodistribution of ¹⁸F-AlF-NOTA-octreotide in Different Organs and Characterization of Uptake in Neuroendocrine Neoplasms

   Purpose

   The aims of this study were threefold: [ 1 ] to describe the biodistribution of ¹⁸ F-AlF-NOTA-octreotide ( ¹⁸ F-OC) in normal organs; [ 2 ] to...

   Jiale Hou, Tingting Long, ... Shuo Hu in Molecular Imaging and Biology

   Article 06 July 2021
   

9. Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects

   Recently, positron emission tomography (PET) with fibroblast activation protein inhibitor (FAPI) has gained significant attention as an advanced...

   Yuji Nakamoto, Shingo Baba, ... Tomoya Uehara in Annals of Nuclear Medicine

   Article 20 October 2023
   

10. Diffusely increased breast uptake of [¹⁸F]AlF-NOTA-FAPI-04 related to menstrual status in a patient with papillary thyroid cancer

    Tao He, **angyu Li, ... Huawei Cai in European Journal of Nuclear Medicine and Molecular Imaging

    Article 27 February 2023
    

11. Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review

    Rheumatoid Arthritis (RA) is a systemic inflammatory disorder that commonly presents with polyarthritis but can have multisystemic involvement and...

    Shashi B. Singh, Sambhawana Bhandari, ... Mona-Elisabeth Revheim in Annals of Nuclear Medicine

    Article Open access 26 January 2024
    

12. A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 36th Annual Congress of the European Association of Nuclear Medicine (EANM), September 9th – 13th, 2023, Vienna

    in memo - Magazine of European Medical Oncology

    Article 01 December 2023

13. Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [¹⁸F]-labeled glycopeptide-containing FAPI with [¹⁸F]FAPI-42

    Purpose

    Research on fibroblast activating protein (FAP)-targeting inhibitor (FAPI) has become an important focus for cancer imaging and radiotherapy....

    Jiawen Huang, LiLan Fu, ... Ganghua Tang in European Journal of Nuclear Medicine and Molecular Imaging

    Article 02 June 2023
    

14. ¹⁸F-FAPI PET/CT performs better in evaluating mediastinal and hilar lymph nodes in patients with lung cancer: comparison with ¹⁸F-FDG PET/CT

    Background

    The aim of this study was to evaluate the efficacy of fluorine 18 ( ¹⁸ F) labeled fibroblast activation protein inhibitor (FAPI) in...

    Yuyun Sun, Yun Sun, ... **gyi Cheng in European Journal of Medical Research

    Article Open access 03 January 2024
    

15. Current research topics in FAPI theranostics: a bibliometric analysis

    Purpose

    The study aimed to provide a comprehensive bibliometric overview of the current scientific publications on fibroblast activation protein...

    Andor F. van den Hoven, Ruth G. M. Keijsers, ... Jules Lavalaye in European Journal of Nuclear Medicine and Molecular Imaging

    Article 28 November 2022
    

16. [¹⁸F]FAPI adds value to [¹⁸F]FDG PET/CT for diagnosing lymph node metastases in stage I-IIIA non-small cell lung cancer: a prospective study

    Background

    This study investigates the value of fluorine 18 ([ ¹⁸ F])-labeled fibroblast activation protein inhibitor (FAPI) for lymph node (LN)...

    Youcai Li, Yin Zhang, ... **nlu Wang in Cancer Imaging

    Article Open access 03 June 2024
    

17. A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [⁶⁸Ga]Ga-PSMA-11

    Background

    The current generation of radiolabeled PSMA-targeting therapeutic agents is limited by prominent salivary gland binding, which results in...

    Steve S. Huang, Frank P. DiFilippo, ... Warren D. Heston in EJNMMI Radiopharmacy and Chemistry

    Article Open access 30 January 2024
    

18. Beyond ⁶⁸Ga-labeled somatostatin analogues: is it time to say goodbye to [⁶⁸Ga]DOTA-conjugated peptides for neuroendocrine neoplasms?

    Gaia Ninatti, Paola Mapelli in European Journal of Nuclear Medicine and Molecular Imaging

    Article 24 May 2023

19. EANM-Springer Award winners 2023

    in European Journal of Nuclear Medicine and Molecular Imaging

    Article 28 December 2023
    

20. Highlight selection of radiochemistry and radiopharmacy developments by editorial board

    Background

    The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in...

    Oliver C. Kiss, Peter J. H. Scott, ... Francisco Alves in EJNMMI Radiopharmacy and Chemistry

    Article Open access 23 March 2023